title: [Therapeutic update in gastroenterology].
abstract: During the last decade, advances in molecular biology and biotechnology allowed, the development of biological treatments aimed at more precise targets. New algorithms in inflammatory bowel diseases, chronic hepatitis C and digestive oncology are examples of the marked progress achieved by these therapies.
authors.affiliation: Service d'Hépato-Gastroentérologie, CHU Sart Tilman, ULg, Liège. Jacques.Belaiche@chu.ulg.ac.be
authors.forename: J
authors.initials: J
authors.lastname: Belaiche
authors.forename: J
authors.initials: J
authors.lastname: Delwaide
authors.forename: M
authors.initials: M
authors.lastname: Polus
authors.forename: E
authors.initials: E
authors.lastname: Louis
mesh_terms: D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D007372:Interferons / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000188:drug therapy*; D012254:Ribavirin / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D014409:Tumor Necrosis Factor-alpha; D012254:Ribavirin; D007372:Interferons